Skip to content

Author

N. Takeda

We have 3 of 329 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Ventricular Fibrillation in a Patient with Marfan Syndrome without Severe Valvular Disease or Ventricular Dysfunction.

This case underscores the risk of VAs in MFS even in the absence of ventricular dysfunction or severe valvular diseases, and a combination of various factors, such as subtle depolarization abnormalities, moderate valvular abnormalities, and underlying myocardial damage, may contribute to the development of VF.

Mai Ishiwata, Kazutaka Ueda, S. Inoue et al. · 0 citations
Open access Aug 2026

Cardiovascular-Kidney-Metabolic Syndrome Age Derived From Routine Health Checkup and Claims Data - Large-Scale Epidemiological Study.

CKM syndrome age may serve as an intuitive tool for communicating integrated cardiovascular risk beyond chronological age in health checkup settings and higher discrimination than chronological age alone across all outcomes and both sexes.

Yuta Suzuki, Hidehiro Kaneko, Masachika Nishikawa et al. · 0 citations
Open access Sep 2026

Blood pressure and cardiovascular risk in adults with non-proteinuric chronic kidney disease without diabetes.

A U-shaped association observed among individuals receiving antihypertensive treatment suggests that the relationship between BP and cardiovascular risk may be complex in this population, highlighting the potential importance of individualized clinical assessment.

Yuta Suzuki, Masachika Nishikawa, Hidehiro Kaneko et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.